NRAS and neoplasm: Samples from two patients (P19 and P43) were evaluated to investigate patients having short PFS and high ctDNA fractional abundance, one patient (P61) was evaluated due to lack of measurable cfDNA NRAS mutation, and two patients (P31 and P68) were evaluated due to large decrease and increase, respectively, in CT measured tumour burden.